Kymera Therapeutic

+$0.05 (+0.11%) Today
$0.00 (0.00%) As of 8:00 AM UTC after-hours

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell KYMR and other ETFs, options, and stocks.

About KYMR

Kymera Therapeutics, Inc. operates as a biotechnology company, which engages in curing untreatable diseases. It focuses on discovering and developing novel small molecule therapeutics.

CEO
Nello Mainolfi
Employees
75
Headquarters
Watertown, Massachusetts
Founded
2015

KYMR Key Statistics

Market Cap
2.19B
Price-Earnings Ratio
—
Dividend Yield
—
Average Volume
462.82K
High Today
$45.89
Low Today
$43.73
Open Price
$45.14
Volume
407.10K
52 Week High
$91.92
52 Week Low
$25.43

KYMR Earnings

-$0.39
-$0.26
-$0.13
$0.00
Q3 FY20
Q4 FY20
Q1 FY21
Q2 FY21
Estimated
— per share
Actual
Expected Aug 5, Pre-Market
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, a registered broker-dealer and Member SIPC. Full disclosure